Photo by miteneva from unsplash
1 Talany G, Guo M, Etminan M. Risk of intraocular hemorrhage with new oral anticoagulants. Eye 2016; 174: 3158–3163. 2 Grzybowski A, Ascaso FJ, Kupidura-Majewski K, Packer M. Continuation of… Click to show full abstract
1 Talany G, Guo M, Etminan M. Risk of intraocular hemorrhage with new oral anticoagulants. Eye 2016; 174: 3158–3163. 2 Grzybowski A, Ascaso FJ, Kupidura-Majewski K, Packer M. Continuation of anticoagulant and antiplatelet therapy during phacoemulsification cataract surgery. Curr Opin Ophthalmol 2015; 26: 28–33. 3 Olson RJ, Braga-Mele R, Chen SH, Miller KM, Pineda R 2nd, Tweeten JP et al. Cataract in the Adult eye preferred practice pattern. Ophthalmology 2017; 124: P1–P119. 4 Jamula E, Anderson J, Douketis JD. Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. Thromb Res 2009; 124: 292–299. 5 Caldeira D, Canastro M, Barra M, Ferreira A, Costa J, Pinto FJ et al. Risk of substantial intraocular bleeding with novel oral anticoagulants systematic review and meta-analysis. JAMA Ophthalmol 2015; 133: 834–839.
Journal Title: Eye
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!